Commentary calls for greater transparency in highlighting social value of research

May 1, 2013, UC Davis

In a commentary published in the May issue of Mayo Clinic Proceedings, UC Davis bioethicist Mark Yarborough proposes that more information about the social value of individual research studies be made available to prospective research participants during the informed consent process so they are more aware of the degree to which a study has the potential to improve health for all.

" as a whole drives important, even lifesaving, drug discoveries," said Yarborough. "But not all clinical trials are created equal, and our current regulatory practices don't provide participants with sufficient information to assess choices about volunteering for clinical trials."

As an example, Yarborough compares research with a high social value, such as the use of to improve quality of life for Huntington's disease patients, with "me too" drug studies, which have less social value as they are conducted to obtain data that allows a new drug to compete in the health-care marketplace even though existing effective and often cheaper therapeutics are already available.

While the stem cell study holds promise as a novel and for affected individuals worldwide, the drug study may lead to a more expensive drug than existing drugs already on the market, which can result in higher co-pays and higher insurance premiums. In this scenario, Yarborough said patients have not improved their health but have worsened their financial well being. He asks, how many patients would want to volunteer for a study that helps a drug company do this?

Yarborough believes it is possible to improve the informed consent process so that it includes a clear declaration about whether a clinical trial is investigating a way to potentially improve current medical care and explains why it does—or does not—have the potential to achieve this outcome.

"We owe the public honest disclosure about why any given trial is being conducted so that potential volunteers understand the extent to which a trial, if completed, could promote the common good," Yarborough said. "The process is one way to give prospective research participants greater awareness of unimportant, important and very important research conducted within an institution."

Yarborough hopes his commentary generates discussion and ultimately consensus in the scientific community about the best ways to increase transparency in research to help build public trust.

Explore further: Experts discuss ways to embed patient voices and values in clinical research

More information: The commentary "Increasing enrollment in drug trials: The need for greater transparency about the social value of research in recruitment efforts," is available online at dx.doi.org/10.1016/j.mayocp.2013.03.001

Related Stories

Experts discuss ways to embed patient voices and values in clinical research

April 30, 2013
There is worldwide concern in the biomedical research community that enrollment in clinical trials is lagging, putting clinical research and consequent benefits to society in jeopardy. Experts explore ways to embed patient ...

Study calls for drug trial patients to receive more information about effects of placebos

June 28, 2012
Research carried out at the University of Southampton has concluded that participants in drug trials should be better informed about the potential significant benefits and possible side-effects of placebos.

Commentary: Drug companies must report clinical trial results, even when they won't lead to a product

September 28, 2011
Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is ...

Penn-developed online informed consent tool could boost number of patients in cancer clinical trials

October 3, 2011
A new multimedia informed consent tool accessed via the Internet may make it easier for cancer patients to understand and feel comfortable enrolling in clinical trials, according a study conducted by researchers in the Perelman ...

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.